• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于微环境变化的生物材料局部响应设计在心肌梗死中的应用。

Application of locally responsive design of biomaterials based on microenvironmental changes in myocardial infarction.

作者信息

Wang Yiren, Li Junlin, Han Hukui, Huang Huihui, Du Huan, Cheng Lianying, Ma Cui, Cai Yongxiang, Li Gang, Tao Jianhong, Cheng Panke

机构信息

Institute of Cardiovascular Diseases & Department of Cardiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

出版信息

iScience. 2023 Aug 18;26(9):107662. doi: 10.1016/j.isci.2023.107662. eCollection 2023 Sep 15.

DOI:10.1016/j.isci.2023.107662
PMID:37670787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10475519/
Abstract

Morbidity and mortality caused by acute myocardial infarction (AMI) are on the rise, posing a grave threat to the health of the general population. Up to now, interventional, surgical, and pharmaceutical therapies have been the main treatment methods for AMI. Effective and timely reperfusion therapy decreases mortality, but it cannot stimulate myocardial cell regeneration or reverse ventricular remodeling. Cell therapy, gene therapy, immunotherapy, anti-inflammatory therapy, and several other techniques are utilized by researchers to improve patients' prognosis. In recent years, biomaterials for AMI therapy have become a hot spot in medical care. Biomaterials furnish a microenvironment conducive to cell growth and deliver therapeutic factors that stimulate cell regeneration and differentiation. Biomaterials adapt to the complex microenvironment and respond to changes in local physical and biochemical conditions. Therefore, environmental factors and material properties must be taken into account when designing biomaterials for the treatment of AMI. This article will review the factors that need to be fully considered in the design of biological materials.

摘要

急性心肌梗死(AMI)所致的发病率和死亡率呈上升趋势,对普通人群的健康构成严重威胁。到目前为止,介入治疗、手术治疗和药物治疗一直是AMI的主要治疗方法。有效且及时的再灌注治疗可降低死亡率,但它无法刺激心肌细胞再生或逆转心室重构。研究人员利用细胞治疗、基因治疗、免疫治疗、抗炎治疗及其他一些技术来改善患者的预后。近年来,用于AMI治疗的生物材料已成为医疗保健领域的一个热点。生物材料提供有利于细胞生长的微环境,并递送刺激细胞再生和分化的治疗因子。生物材料能适应复杂的微环境并对局部物理和生化条件的变化做出反应。因此,在设计用于治疗AMI的生物材料时,必须考虑环境因素和材料特性。本文将综述生物材料设计中需要充分考虑的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/37a2a7ee5ab0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/0a9dadcb676a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/50aa644dada6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/49a20bad7856/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/9aff3ecf9f00/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/37a2a7ee5ab0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/0a9dadcb676a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/50aa644dada6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/49a20bad7856/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/9aff3ecf9f00/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1913/10475519/37a2a7ee5ab0/gr4.jpg

相似文献

1
Application of locally responsive design of biomaterials based on microenvironmental changes in myocardial infarction.基于微环境变化的生物材料局部响应设计在心肌梗死中的应用。
iScience. 2023 Aug 18;26(9):107662. doi: 10.1016/j.isci.2023.107662. eCollection 2023 Sep 15.
2
Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.血管紧张素转换酶抑制剂对心肌梗死后心室重构和生存率的影响。
Ann Pharmacother. 1993 Jun;27(6):755-66. doi: 10.1177/106002809302700617.
3
Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.具有siCCR2的光致发光介孔硅纳米颗粒改善急性心肌梗死后间充质基质细胞移植的效果。
Theranostics. 2015 Jun 25;5(10):1068-82. doi: 10.7150/thno.11517. eCollection 2015.
4
Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).ST段抬高型急性冠状动脉综合征(<12小时)的院前溶栓治疗管理
Minerva Anestesiol. 2005 Jun;71(6):297-302.
5
Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial.四种抗血小板/他汀联合策略对接受药物侵入性治疗策略的急性心肌梗死患者免疫和炎症反应的影响:急性心肌梗死中B和T淋巴细胞评估(BATTLE-AMI)研究的设计与原理:一项随机对照试验的研究方案
Trials. 2017 Dec 19;18(1):601. doi: 10.1186/s13063-017-2361-1.
6
Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarction: myocardial reperfusion revisited.急性心肌梗死后血管紧张素转换酶抑制的临床益处:再谈心肌再灌注
J Hypertens Suppl. 1996 Dec;14(6):S15-9.
7
[Effects of reperfusion arrhythmia on myocardial apoptosis and left ventricular remodeling in patients with acute myocardial infarction].[再灌注心律失常对急性心肌梗死患者心肌细胞凋亡及左心室重构的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Jan;35(1):59-62.
8
Surgery as early revascularization after acute myocardial infarction.急性心肌梗死后早期血运重建的手术治疗
Anadolu Kardiyol Derg. 2008 Nov;8 Suppl 2:84-92.
9
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.急性心肌梗死中祖细胞移植与再生增强:TOPCARE-AMI试验的最终一年结果。
J Am Coll Cardiol. 2004 Oct 19;44(8):1690-9. doi: 10.1016/j.jacc.2004.08.014.
10
Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).75岁以上急性心肌梗死患者的当前治疗——来自柏林心肌梗死注册研究(BHIR)的数据。
Clin Res Cardiol. 2006 Jul;95(7):360-7. doi: 10.1007/s00392-006-0393-8. Epub 2006 Jun 13.

本文引用的文献

1
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction.急性心肌梗死后左心室收缩功能障碍或肺充血的患病率及其预后影响。
ESC Heart Fail. 2023 Apr;10(2):1347-1357. doi: 10.1002/ehf2.14301. Epub 2023 Feb 2.
2
Mitochondrial disorder and treatment of ischemic cardiomyopathy: Potential and advantages of Chinese herbal medicine.线粒体疾病与缺血性心肌病的治疗:中草药的潜力与优势
Biomed Pharmacother. 2023 Mar;159:114171. doi: 10.1016/j.biopha.2022.114171. Epub 2023 Jan 13.
3
Growth and differentiation factor-7 immobilized, mechanically strong quadrol-hexamethylene diisocyanate-methacrylic anhydride polyurethane polymer for tendon repair and regeneration.
固定化生长分化因子-7的、机械强度高的四乙烯五胺-六亚甲基二异氰酸酯-甲基丙烯酸酐聚氨酯聚合物用于肌腱修复与再生
Acta Biomater. 2022 Dec;154:108-122. doi: 10.1016/j.actbio.2022.10.029. Epub 2022 Oct 19.
4
Inhibition of cardiomyocyte apoptosis post-acute myocardial infarction through the efficient delivery of microRNA-24 by silica nanoparticles.通过二氧化硅纳米颗粒有效递送微小RNA-24抑制急性心肌梗死后心肌细胞凋亡。
Nanoscale Adv. 2021 Sep 17;3(22):6379-6385. doi: 10.1039/d1na00568e. eCollection 2021 Nov 9.
5
A pH/H O /MMP9 Time-Response Gel System with Sparc Tregs Derived Extracellular Vesicles Promote Recovery After Acute Myocardial Infarction.一种具有 Sparc Tregs 衍生细胞外囊泡的 pH/H O /MMP9 时间响应凝胶系统可促进急性心肌梗死后的恢复。
Adv Healthc Mater. 2022 Nov;11(22):e2200971. doi: 10.1002/adhm.202200971. Epub 2022 Sep 9.
6
Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model.富含 MSC 衍生细胞外囊泡的去细胞心脏支架可限制心室重构,并在心肌梗死猪模型中发挥局部和全身免疫调节作用。
Theranostics. 2022 Jun 6;12(10):4656-4670. doi: 10.7150/thno.72289. eCollection 2022.
7
An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury.一种用于恢复线粒体功能和分级减轻氧化应激以减少心肌缺血再灌注损伤的可注射线粒体靶向纳米药物负载水凝胶。
Biomaterials. 2022 Aug;287:121656. doi: 10.1016/j.biomaterials.2022.121656. Epub 2022 Jun 28.
8
Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction.载notoginsenoside R1 的介孔硅纳米粒通过炎症细胞靶向损伤部位促进心肌梗死后的心脏修复。
Redox Biol. 2022 Aug;54:102384. doi: 10.1016/j.redox.2022.102384. Epub 2022 Jun 24.
9
The Role of CXC Chemokines in Cardiovascular Diseases.CXC趋化因子在心血管疾病中的作用。
Front Pharmacol. 2022 May 20;12:765768. doi: 10.3389/fphar.2021.765768. eCollection 2021.
10
Diagnosis and Treatment of Acute Coronary Syndromes: A Review.急性冠状动脉综合征的诊断与治疗:综述。
JAMA. 2022 Feb 15;327(7):662-675. doi: 10.1001/jama.2022.0358.